Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Debt Ratio (2019 - 2025)

Vivos Therapeutics' Debt Ratio history spans 4 years, with the latest figure at 0.35 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.35 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 0.35 (changed N/A YoY), and the annual figure for FY2025 was 0.35, changed.
  • Debt Ratio for Q4 2025 was 0.35 at Vivos Therapeutics, up from 0.34 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.35 in Q4 2025 to a low of 0.03 in Q2 2021.